{"cmr":"de-cm-kg/XETRA/HPHA","since":null,"total":11,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-11-04","event_type":"corporate_news","title":"Heidelberg Pharma präsentiert neue klinische Daten ihrer ATAC-Kandidaten auf der Jahrestagung 2026 der American Society of Hematology (ASH) | Corporate - EQS News","category":"corporate-news","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate-news/heidelberg-pharma-praesentiert-neue-klinische-daten-ihrer-atac-kandidaten-auf-der-jahrestagung-2026-der-american-society-of-hematology-ash/fc59a7e1-0e2d-4844-a204-589f493eb0ec_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SamjHU9pDOKKBY0aG-75eONNLaBh98PrgZ5_AkLUxOFJT8m4hu4EofnRZike4xDUimqKJaiiaGWR05CAsGxaBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-11-04","event_type":"corporate_news","title":"Heidelberg Pharma to Present New Clinical Data on its ATAC Candidates at the ASH Annual Meeting 2026 | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/heidelberg-pharma-to-present-new-clinical-data-on-its-atac-candidates-at-the-ash-annual-meeting-2026/fc59a7e1-0e2d-4844-a204-589f493eb0ec_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fUSvQe6vsiVbxJuYmbk93WyGsGQXTRe8KqDz0P-IdLbpxPXYsBRS35a7NTLtQuMcgt9FrrflCn0lprYR6XOEAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-10-15","event_type":"corporate_news","title":"Heidelberg Pharma berichtet über die ersten neun Monate des Geschäftsjahres 2026 | Corporate - EQS News","category":"corporate-news","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate-news/heidelberg-pharma-berichtet-ueber-die-ersten-neun-monate-des-geschaeftsjahres-2026/9d687761-d970-4293-9930-f96bf9048d1d_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"j0yUxJLPz7BAuhOC_ShLR2lJ9BmEAVOPAi99NDMnNAXjkThkf4nNGPaPqy_KZvwxtVLHuL5-6HlaCkVFp0agCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-10-14","event_type":"corporate_news","title":"Heidelberg Pharma Reports on the First Nine Months of Financial Year 2026 | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/heidelberg-pharma-reports-on-the-first-nine-months-of-financial-year-2026/9d687761-d970-4293-9930-f96bf9048d1d_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aKP6U0ItMdPXuZvbjBChYP-UMxLEVu6TgcuGo6NbhL01dg-6Cl9LDFH6Yjg-uiUBq4qU3oDt1LAHUOCEwPXEDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-09-07","event_type":"corporate_news","title":"Heidelberg Pharma präsentiert neue klinische Daten ihres führenden ATAC-Kandidaten pamlectabart tismanitin auf der Jahrestagung 2026 der International Myeloma Society | Corporate - EQS News","category":"corporate-news","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate-news/heidelberg-pharma-praesentiert-neue-klinische-daten-ihres-fuehrenden-atac-kandidaten-pamlectabart-tismanitin-auf-der-jahrestagung-2026-der-international-myeloma-society/0379a100-d47c-4869-a67d-252194baa541_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CkWIuWiU8THIixgAWUE-_lfvk9QlpgGVhNlo2sNcXAJOwmZaDF2ws9tC5fcxcstOvODbCwIcSHMVhh6QiaYqCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-09-07","event_type":"corporate_news","title":"Heidelberg Pharma to Present New Clinical Data on Lead ATAC Candidate Pamlectabart Tismanitin at International Myeloma Society Annual Meeting 2026 | Corporate - EQS News","category":"corporate","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/heidelberg-pharma-to-present-new-clinical-data-on-lead-atac-candidate-pamlectabart-tismanitin-at-international-myeloma-society-annual-meeting-2026/0379a100-d47c-4869-a67d-252194baa541","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"bYoDM-l-0X-a26kkW7HaCNbiPtdNIJfPdoDYwu4YCe41V5h2wMqTcH8YNrr6CxMkpz_XQQP1yEKLitq-sH4dCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-08-28","event_type":"corporate_news","title":"Heidelberg Pharma und Huadong Medicine unterzeichnen weitere Kooperationsvereinbarung zur gemeinsamen Entwicklung neuer Antikörper-Wirkstoff-Konjugate | Corporate - EQS News","category":"corporate","language":"de","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/heidelberg-pharma-und-huadong-medicine-unterzeichnen-weitere-kooperationsvereinbarung-zur-gemeinsamen-entwicklung-neuer-antikoerper-wirkstoff-konjugate/e5e91191-860f-484b-8bce-cd15a653ee3d_de","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fPIw-EBUzrVp6RHzQGiyXHH2HlPWszypWe9fmSjQFmYbi0fyKrHTIeXAGJF7b86z2cKj4lJsnrUwWg_EaHEBAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-08-26","event_type":"corporate_news","title":"Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/de/news/corporate/heidelberg-pharma-ag-and-huadong-medicine-receive-nmpa-approval-for-clinical-trial-of-hdp-101-combination-therapy-in-china/fbba94a1-6cdb-4dbb-8c99-270b67f0ac45_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hbfEEfRmeuXT-Q3WlIVQ81y-93Rs6NSa8HT00y3msn4z8OxAejgwjS4Co1QxYE4AUuq93UnPnyPGA1UXbuejDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-04-17","event_type":"corporate_news","title":"Heidelberg Pharma Announces Change in Executive Board","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/heidelberg-pharma-announces-change-in-executive-board/19a10578-9fdf-4847-8451-e5344389f3f1_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NRbm6t_LOZDy0uik5j9syvTawhP_fKIkgcF5umq-Pdie-T8ZyBicWIgZ0t48qalrTjOTOEgc7iwl9UpNr7dhBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-04-17","event_type":"newswire_release","title":"Heidelberg Pharma Announces Change in Executive Board","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/heidelberg-pharma-announces-change-in-executive-board/19a10578-9fdf-4847-8451-e5344389f3f1_en","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"yHDtWlSmaz7eNqNSgtjB40EHGC1Q5zspIPx3HTyTpsxJ0AiUQ5ZQY8M_Cg9wfJGsN7RWxUCQvXRz2F-FOq8pDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/HPHA","date":"2026-03-18","event_type":"corporate_news","title":"Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China | Corporate - EQS News","category":"corporate","language":"en","wire":"EQS News","source":"EQS News","url":"https://www.eqs-news.com/news/corporate/heidelberg-pharma-to-receive-milestone-payment-from-partner-huadong-for-clinical-study-with-hdp-101-in-china/c21f713a-4aaf-4919-9a29-9425a44df8ad_en","read_by":"Tavily search (eqs-news.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"gNpozZ9yZpkA1l7L_CuFs_FR0HlGoujomjyFQCizhenHhRfiVMSMlsPIyJl-XIyzJszMGVcYWmxjKDa0q3f_Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}